Empinado, Bb Boy .

HRN: 26-16-11  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/31/2024
10/31/2024
IV
500mg
1h
Pcap D
Waiting Final Action 
10/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/31/2024
11/07/2024
IV
50mg
Q12h
Pcap D
Waiting Final Action 
11/01/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/01/2024
11/08/2024
IV DRIP
60mg
Q12
PCAP D
Waiting Final Action 
11/01/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/01/2024
11/08/2024
IV
800
Q6
PCAP D
Waiting Final Action 
11/01/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
11/01/2024
11/08/2024
TOPICAL
1 Squint
OD
Eye Infection
Waiting Final Action 
11/01/2024
OXACILLIN 500MG (VIAL)
11/01/2024
11/08/2024
IV DRIP
400mg
Q6
Pcap D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: